STOCK TITAN
  1. Home
  2. Sec-filings
  3. CALC
  4. [EFFECT] CalciMedica, Inc. SEC Filing

[EFFECT] CalciMedica, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 11, 2026 4:00 P.M.
Form: S-3
CIK: 0001534133
Company Name: CalciMedica, Inc.
File Number: 333-293972

Source: View Original Filing on SEC EDGAR

CALCIMEDICA INC

NASDAQ:CALC

View CALC Stock Overview →

CALC Rankings

#6353 Ranked by Market Cap
N/A Ranked by Dividends

CALC Latest News

Mar 3, 2026
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
Jan 28, 2026
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
Nov 12, 2025
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Nov 12, 2025
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
Nov 10, 2025
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025

CALC Latest SEC Filings

Mar 3, 2026
[S-3] CalciMedica, Inc. Shelf Registration Statement
Mar 3, 2026
[10-K] CalciMedica, Inc. Files Annual Report
Mar 3, 2026
[8-K] CalciMedica, Inc. Reports Material Event
Feb 6, 2026
[SCHEDULE 13G/A] CalciMedica, Inc. Amended Passive Investment Disclosure
Jan 28, 2026
[8-K] CalciMedica, Inc. Reports Material Event

CALC Stock Data

11.43M
10.99M
Biotechnology
Pharmaceutical Preparations
Link
United States
LA JOLLA